188 related articles for article (PubMed ID: 29713515)
21. Genome-wide transcription factor-binding maps reveal cell-specific changes in the regulatory architecture of human HSPCs.
Subramanian S; Thoms JAI; Huang Y; Cornejo-Páramo P; Koch FC; Jacquelin S; Shen S; Song E; Joshi S; Brownlee C; Woll PS; Chacon-Fajardo D; Beck D; Curtis DJ; Yehson K; Antonenas V; O'Brien T; Trickett A; Powell JA; Lewis ID; Pitson SM; Gandhi MK; Lane SW; Vafaee F; Wong ES; Göttgens B; Alinejad-Rokny H; Wong JWH; Pimanda JE
Blood; 2023 Oct; 142(17):1448-1462. PubMed ID: 37595278
[TBL] [Abstract][Full Text] [Related]
22. Stem Cell Leukemia: how a TALented actor can go awry on the hematopoietic stage.
Correia NC; Arcangeli ML; Pflumio F; Barata JT
Leukemia; 2016 Oct; 30(10):1968-1978. PubMed ID: 27443261
[TBL] [Abstract][Full Text] [Related]
23. E Protein Transcription Factors as Suppressors of T Lymphocyte Acute Lymphoblastic Leukemia.
Parriott G; Kee BL
Front Immunol; 2022; 13():885144. PubMed ID: 35514954
[TBL] [Abstract][Full Text] [Related]
24. Transcriptional control of fetal liver hematopoiesis: dominant negative effect of the overexpression of the LIM domain mutants of LMO2.
Terano T; Zhong Y; Toyokuni S; Hiai H; Yamada Y
Exp Hematol; 2005 Jun; 33(6):641-51. PubMed ID: 15911088
[TBL] [Abstract][Full Text] [Related]
25. The transcription factor TAL1 and miR-17-92 create a regulatory loop in hematopoiesis.
Meyer A; Herkt S; Kunze-Schumacher H; Kohrs N; Ringleb J; Schneider L; Kuvardina ON; Oellerich T; Häupl B; Krueger A; Seifried E; Bonig H; Lausen J
Sci Rep; 2020 Dec; 10(1):21438. PubMed ID: 33293632
[TBL] [Abstract][Full Text] [Related]
26. SCL and LMO1 alter thymocyte differentiation: inhibition of E2A-HEB function and pre-T alpha chain expression.
Herblot S; Steff AM; Hugo P; Aplan PD; Hoang T
Nat Immunol; 2000 Aug; 1(2):138-44. PubMed ID: 11248806
[TBL] [Abstract][Full Text] [Related]
27. The stepwise specification of embryonic stem cells to hematopoietic fate is driven by sequential exposure to Bmp4, activin A, bFGF and VEGF.
Pearson S; Sroczynska P; Lacaud G; Kouskoff V
Development; 2008 Apr; 135(8):1525-35. PubMed ID: 18339678
[TBL] [Abstract][Full Text] [Related]
28. A novel complex, RUNX1-MYEF2, represses hematopoietic genes in erythroid cells.
van Riel B; Pakozdi T; Brouwer R; Monteiro R; Tuladhar K; Franke V; Bryne JC; Jorna R; Rijkers EJ; van Ijcken W; Andrieu-Soler C; Demmers J; Patient R; Soler E; Lenhard B; Grosveld F
Mol Cell Biol; 2012 Oct; 32(19):3814-22. PubMed ID: 22801375
[TBL] [Abstract][Full Text] [Related]
29. Role of transcriptional corepressor ETO2 in erythroid cells.
Fujiwara T; Alqadi YW; Okitsu Y; Fukuhara N; Onishi Y; Ishizawa K; Harigae H
Exp Hematol; 2013 Mar; 41(3):303-15.e1. PubMed ID: 23127762
[TBL] [Abstract][Full Text] [Related]
30. The basic helix-loop-helix transcription factor TAL1/SCL inhibits the expression of the p16INK4A and pTalpha genes.
Hansson A; Manetopoulos C; Jönsson JI; Axelson H
Biochem Biophys Res Commun; 2003 Dec; 312(4):1073-81. PubMed ID: 14651981
[TBL] [Abstract][Full Text] [Related]
31. TAL1 as a master oncogenic transcription factor in T-cell acute lymphoblastic leukemia.
Sanda T; Leong WZ
Exp Hematol; 2017 Sep; 53():7-15. PubMed ID: 28652130
[TBL] [Abstract][Full Text] [Related]
32. ETO2 coordinates cellular proliferation and differentiation during erythropoiesis.
Goardon N; Lambert JA; Rodriguez P; Nissaire P; Herblot S; Thibault P; Dumenil D; Strouboulis J; Romeo PH; Hoang T
EMBO J; 2006 Jan; 25(2):357-66. PubMed ID: 16407974
[TBL] [Abstract][Full Text] [Related]
33. The Hematopoietic Transcription Factors RUNX1 and ERG Prevent AML1-ETO Oncogene Overexpression and Onset of the Apoptosis Program in t(8;21) AMLs.
Mandoli A; Singh AA; Prange KHM; Tijchon E; Oerlemans M; Dirks R; Ter Huurne M; Wierenga ATJ; Janssen-Megens EM; Berentsen K; Sharifi N; Kim B; Matarese F; Nguyen LN; Hubner NC; Rao NA; van den Akker E; Altucci L; Vellenga E; Stunnenberg HG; Martens JHA
Cell Rep; 2016 Nov; 17(8):2087-2100. PubMed ID: 27851970
[TBL] [Abstract][Full Text] [Related]
34. Aberrant activation of the GIMAP enhancer by oncogenic transcription factors in T-cell acute lymphoblastic leukemia.
Liau WS; Tan SH; Ngoc PCT; Wang CQ; Tergaonkar V; Feng H; Gong Z; Osato M; Look AT; Sanda T
Leukemia; 2017 Aug; 31(8):1798-1807. PubMed ID: 28028313
[TBL] [Abstract][Full Text] [Related]
35. Loss of thymocyte competition underlies the tumor suppressive functions of the E2a transcription factor in T lymphocyte acute lymphoblastic leukemia.
Parriott G; Hegermiller E; Morman RE; Frank C; Saygin C; Stock W; Bartom ET; Kee BL
bioRxiv; 2023 Apr; ():. PubMed ID: 37163059
[TBL] [Abstract][Full Text] [Related]
36. SCL: from the origin of hematopoiesis to stem cells and leukemia.
Lécuyer E; Hoang T
Exp Hematol; 2004 Jan; 32(1):11-24. PubMed ID: 14725896
[TBL] [Abstract][Full Text] [Related]
37. The LIM-only protein Lmo2 is a bridging molecule assembling an erythroid, DNA-binding complex which includes the TAL1, E47, GATA-1 and Ldb1/NLI proteins.
Wadman IA; Osada H; Grütz GG; Agulnick AD; Westphal H; Forster A; Rabbitts TH
EMBO J; 1997 Jun; 16(11):3145-57. PubMed ID: 9214632
[TBL] [Abstract][Full Text] [Related]
38. Mitogen-activated protein kinase mediates erythropoietin-induced phosphorylation of the TAL1/SCL transcription factor in murine proerythroblasts.
Tang T; Prasad KS; Koury MJ; Brandt SJ
Biochem J; 1999 Nov; 343 Pt 3(Pt 3):615-20. PubMed ID: 10527940
[TBL] [Abstract][Full Text] [Related]
39. The TAL1/Scl basic helix-loop-helix protein blocks myogenic differentiation and E-box dependent transactivation.
Hofmann TJ; Cole MD
Oncogene; 1996 Aug; 13(3):617-24. PubMed ID: 8760303
[TBL] [Abstract][Full Text] [Related]
40. Cutting Edge: Lymphomyeloid-Primed Progenitor Cell Fates Are Controlled by the Transcription Factor Tal1.
de Pooter RF; Dias S; Chowdhury M; Bartom ET; Okoreeh MK; Sigvardsson M; Kee BL
J Immunol; 2019 May; 202(10):2837-2842. PubMed ID: 30962294
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]